Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search

Coagulation and fibronolysis

Citations 41-50 of 143 total displayed.

Past content (since Jan 1999):

Articles
Functional Analysis of the Fibrinogen A{alpha} Thr312Ala Polymorphism. Effects on Fibrin Structure and Function
Kristina F. Standeven, Peter J. Grant, Angela M. Carter, Thomas Scheiner, John W. Weisel, and Robert A.S. Ariëns
Circulation published April 21, 2003, doi:10.1161/01.CIR.0000066690.89407.CE [Abstract]  

Editorials
Factor VII-Activating Protease: Coagulation, Fibrinolysis, and Atherothrombosis?
Kenneth G. Mann
Circulation 2003;107:654-655, doi:10.1161/01.CIR.0000057382.68508.3D [Full text]  

Brief Rapid Communications
Marburg I Polymorphism of Factor VII–Activating Protease: A Prominent Risk Predictor of Carotid Stenosis
Johann Willeit, Stefan Kiechl, Thomas Weimer, Artur Mair, Peter Santer, Christian J. Wiedermann, and Juergen Roemisch
Circulation 2003;107:667-670; published online before print as doi:10.1161/01.CIR.0000055189.18831.B1 [Abstract] [Full text]  

Current Perspectives
Burgeoning Dilemmas in the Management of Diabetes and Cardiovascular Disease: Rationale for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial
Burton E. Sobel, Robert Frye, and Katherine M. Detre
Circulation 2003;107:636-642, doi:10.1161/01.CIR.0000048897.03553.E4 [Abstract] [Full text]  

Articles
Marburg I Polymorphism of Factor VII-Activating Protease. A Prominent Risk Predictor of Carotid Stenosis
Johann Willeit, Stefan Kiechl, Thomas Weimer, Artur Mair, Peter Santer, Christian J. Wiedermann, and Juergen Roemisch
Circulation published February 3, 2003, doi:10.1161/01.CIR.0000055189.18831.B1 [Abstract]  

Editorials
NO Hope for Patients With Atrial Fibrillation
Michael Rubart and Douglas P. Zipes
Circulation 2002;106:2764-2766, doi:10.1161/01.CIR.0000038983.96121.7F [Full text]  

Basic Science Reports
Downregulation of Endocardial Nitric Oxide Synthase Expression and Nitric Oxide Production in Atrial Fibrillation: Potential Mechanisms for Atrial Thrombosis and Stroke
Hua Cai, Zongming Li, Andreas Goette, Fernando Mera, Clegg Honeycutt, Kristian Feterik, Josiah N. Wilcox, Samuel C. Dudley, Jr, David G. Harrison, and Jonathan J. Langberg
Circulation 2002;106:2854-2858; published online before print as doi:10.1161/01.CIR.0000039327.11661.16 [Abstract] [Full text]  

Clinical Investigations and Reports
Ability of Recombinant Factor VIIa to Reverse the Anticoagulant Effect of the Pentasaccharide Fondaparinux in Healthy Volunteers
Nick R. Bijsterveld, Arno H. Moons, S. Matthijs Boekholdt, Benien E. van Aken, Hein Fennema, Ron J.G. Peters, Joost C.M. Meijers, Harry R. Büller, and Marcel Levi
Circulation 2002;106:2550-2554; published online before print as doi:10.1161/01.CIR.0000038501.87442.02 [Abstract] [Full text]  

Articles
Downregulation of Endocardial Nitric Oxide Synthase Expression and Nitric Oxide Production in Atrial Fibrillation. Potential Mechanisms for Atrial Thrombosis and Stroke
Hua Cai, Zongming Li, Andreas Goette, Fernando Mera, Clegg Honeycutt, Kristian Feterik, Josiah N. Wilcox, Samuel C. Dudley, Jr, David G. Harrison, and Jonathan J. Langberg
Circulation published November 11, 2002, doi:10.1161/01.CIR.0000039327.11661.16 [Abstract]  

Clinical Investigations and Reports
Ability of Recombinant Factor VIIa to Reverse the Anticoagulant Effect of the Pentasaccharide Fondaparinux in Healthy Volunteers
Nick R. Bijsterveld, Arno H. Moons, S. Matthijs Boekholdt, Benien E. van Aken, Hein Fennema, Ron J.G. Peters, Joost C.M. Meijers, Harry R. Büller, and Marcel Levi
Circulation published October 21, 2002, doi:10.1161/01.CIR.0000038501.87442.02 [Abstract]  

[First page]   [Previous page]   [Next page]
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

* Subspecialty Collections Home

* Show  Coagulation and fibronolysis
 collections from other journals.

* Related collections:
 Thrombosis
 Anticoagulant mechanisms
 Anticoagulants
 Arterial thrombosis
 Coagulation and fibronolysis
 Coagulation inhibitors
 Coagulation
 Deep vein thrombosis
 Fibrinogen/fibrin
 Fibrinolysis
 Platelet adhesion
 Platelet function inhibitors
 Platelets
 Thrombin
 Thrombophilia
 Thrombosis risk factors